James Healy - Jan 11, 2022 Form 4 Insider Report for CinCor Pharma, Inc. (CINC)

Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
CINC
Transactions as of
Jan 11, 2022
Transactions value $
$5,200,000
Form type
4
Date filed
1/13/2022, 03:33 PM
Previous filing
Feb 11, 2022
Next filing
Mar 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CINC Common Stock Conversion of derivative security +5.25M 5.25M Jan 11, 2022 By Sofinnova Venture Partners X, L.P. F1, F2
transaction CINC Common Stock Purchase $5.2M +325K +6.19% $16.00 5.57M Jan 11, 2022 By Sofinnova Venture Partners X, L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Series A Preferred Stock Conversion of derivative security $0 -13.6M -100% $0.00* 0 Jan 11, 2022 Common Stock 3.99M By Sofinnova Venture Partners X, L.P. F1, F2
transaction CINC Series B Preferred Stock Conversion of derivative security $0 -4.28M -100% $0.00* 0 Jan 11, 2022 Common Stock 1.26M By Sofinnova Venture Partners X, L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date.
F2 The shares are directly held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X. The Reporting Person is a managing member of SM X and may be deemed to share voting and dispositive power over the shares held by SVP X. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.